Safety and Efficacy Study of Asfotase Alfa in Severely Affected Infants With Hypophosphatasia (HPP)

NCT00744042 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypophosphatasia (HPP)

Interventions

BIOLOGICAL: asfotase alfa

Sponsor

Alexion Pharmaceuticals, Inc.